Demonstrates thymosin β4 drives invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway. TB4 was overexpressed in CRC versus normal tissue and correlated with cancer stage; TB4 upregulation activated ILK, phospho-AKT, and nuclear β-catenin to induce EMT and increase invasion. Identifies the ILK/AKT/β-catenin axis as TB4's oncogenic mechanism in CRC—connecting TB4's cytoskeletal regulatory function to the major Wnt/β-catenin pathway driving colorectal cancer metastasis, and providing mechanistic rationale for TB4 inhibition as a CRC treatment strategy.
Piao, Zhengri; Hong, Chang-Soo; Jung, Mi-Ran; Choi, Chan; Park, Young-Kyu